Phase 3 Real Estate Partners
OFFICE & LABORATORY FACILITY IN WATERTOWN, MA
Designed and built for Phase 3 Real Estate Partners, this project is a 213,500-total-square-foot, four-story office and laboratory facility.
This 213,500 SF, four-story speculative office and laboratory facility was designed for modern research and professional use. It is complemented by a four-story parking garage that accommodates 371 vehicles, providing convenient access for employees and visitors.
The structure utilizes a conventional steel framework supported by cast-in-place concrete foundations, ensuring durability and stability. A flat TPO roof membrane with R-25 insulation enhances energy efficiency and weather resistance, contributing to the overall sustainability of the facility.
The facility includes two dock positions for efficient loading and unloading, supporting the logistics needs of any laboratory operations. It is equipped with a robust 4,000-amp electrical service to meet the high power demands of advanced laboratory equipment.
The striking curtain wall façade not only offers aesthetic appeal but also maximizes natural light within the office and laboratory spaces. An enclosed roof penthouse is included for future tenant equipment, providing flexibility for various operational requirements.
The development spans a five-acre site, which includes the clearing of 25,000 SF for park space, promoting a pleasant outdoor environment for employees and the community. This project exemplifies modern design and functionality, ideal for tenants in the office and laboratory sectors.
PROJECT STATUS
Complete
SIZE
213,500 Square Feet
INDUSTRY
Life Science
Related Projects
ARCO is a trusted contractor for life science facilities, including cGMP manufacturing, medical device manufacturing, laboratories, research and development, speculative life science, pharmaceutical processing, pharmaceutical storage and distribution, and contract research organizations. ARCO is expertly capable of providing efficient, top-tier solutions for the evolving needs of the life sciences and pharmaceutical industries.
